Wells Fargo’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-67,477
Closed -$22M 7677
2024
Q1
$22M Buy
67,477
+10,175
+18% +$2.5M 0.01% 1177
2023
Q4
$10.9M Sell
57,302
-5,848
-9% -$1.11M ﹤0.01% 1635
2023
Q3
$12.6M Sell
63,150
-6,207
-9% -$1.47M ﹤0.01% 1397
2023
Q2
$19.8M Sell
69,357
-16,220
-19% -$4.5M 0.01% 1141
2023
Q1
$18.6M Buy
85,577
+6,769
+9% +$1.32M 0.01% 1179
2022
Q4
$16.2M Buy
78,808
+1,885
+2% +$477K ﹤0.01% 1237
2022
Q3
$21.4M Sell
76,923
-6,763
-8% -$1.72M 0.01% 1033
2022
Q2
$16M Sell
83,686
-180,042
-68% -$31.8M ﹤0.01% 1267
2022
Q1
$54.7M Sell
263,728
-2,343
-0.9% -$386K 0.01% 735
2021
Q4
$47.4M Sell
266,071
-941,716
-78% -$186M 0.01% 798
2021
Q3
$249M Buy
1,207,787
+19,146
+2% +$3.76M 0.05% 340
2021
Q2
$226M Sell
1,188,641
-248,856
-17% -$40.7M 0.05% 368
2021
Q1
$187M Sell
1,437,497
-78,366
-5% -$9.4M 0.04% 415
2020
Q4
$157M Buy
1,515,863
+53,673
+4% +$4.65M 0.04% 462
2020
Q3
$111M Buy
1,462,190
+64,500
+5% +$3.66M 0.03% 516
2020
Q2
$66.2M Buy
1,397,690
+254,347
+22% +$10.5M 0.02% 725
2020
Q1
$37.9M Buy
1,143,343
+847,901
+287% +$33.7M 0.01% 906
2019
Q4
$13M Buy
295,442
+3,710
+1% +$137K ﹤0.01% 1764
2019
Q3
$8.73M Buy
291,732
+181,422
+164% +$7.7M ﹤0.01% 2044
2019
Q2
$6.3M Buy
110,310
+18,890
+21% +$917K ﹤0.01% 2365
2019
Q1
$3.06M Buy
+91,420
New +$3.04M ﹤0.01% 3008

Other funds holding SWAV

Wells Fargo's SWAV Position: Q2 2024 in Review

Wells Fargo sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 67,477 shares — an estimated $22M sold.

Wells Fargo first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $249M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Wells Fargo reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 67,477 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $22M.
  • Wells Fargo first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Wells Fargo's Shockwave Medical, Inc. Common Stock position peaked at $249M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.